InvestorsHub Logo
Followers 829
Posts 119609
Boards Moderated 14
Alias Born 09/05/2002

Re: None

Monday, 10/31/2022 11:45:41 AM

Monday, October 31, 2022 11:45:41 AM

Post# of 1162
BMY scores phase-3 win for Reblozyl in a new MDS indication:

https://www.businesswire.com/news/home/20221029005019/en

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BMY News